EP1165614A4 - Antibodies against phosphomannan that are protective against candidiasis - Google Patents

Antibodies against phosphomannan that are protective against candidiasis

Info

Publication number
EP1165614A4
EP1165614A4 EP00917684A EP00917684A EP1165614A4 EP 1165614 A4 EP1165614 A4 EP 1165614A4 EP 00917684 A EP00917684 A EP 00917684A EP 00917684 A EP00917684 A EP 00917684A EP 1165614 A4 EP1165614 A4 EP 1165614A4
Authority
EP
European Patent Office
Prior art keywords
phosphomannan
candidiasis
protective
antibodies
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00917684A
Other languages
German (de)
French (fr)
Other versions
EP1165614A1 (en
Inventor
Jim E Cutler
Yongmoon Han
Marcia Riesselman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research and Development Institute Inc of Montana State University
Takeda Vaccines Montana Inc
Original Assignee
Research and Development Institute Inc of Montana State University
Ligocyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research and Development Institute Inc of Montana State University, Ligocyte Pharmaceuticals Inc filed Critical Research and Development Institute Inc of Montana State University
Publication of EP1165614A1 publication Critical patent/EP1165614A1/en
Publication of EP1165614A4 publication Critical patent/EP1165614A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00917684A 1999-03-01 2000-03-01 Antibodies against phosphomannan that are protective against candidiasis Withdrawn EP1165614A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12221499P 1999-03-01 1999-03-01
US122214P 1999-03-01
PCT/US2000/005279 WO2000052053A1 (en) 1999-03-01 2000-03-01 Antibodies against phosphomannan that are protective against candidiasis

Publications (2)

Publication Number Publication Date
EP1165614A1 EP1165614A1 (en) 2002-01-02
EP1165614A4 true EP1165614A4 (en) 2002-06-26

Family

ID=22401390

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00917684A Withdrawn EP1165614A4 (en) 1999-03-01 2000-03-01 Antibodies against phosphomannan that are protective against candidiasis

Country Status (5)

Country Link
EP (1) EP1165614A4 (en)
JP (1) JP2002541071A (en)
AU (1) AU3861800A (en)
CA (1) CA2362840A1 (en)
WO (1) WO2000052053A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003222640A1 (en) 2002-04-18 2003-11-03 Board Of Regents Of The University Of Texas System Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
SE0203099D0 (en) * 2002-10-21 2002-10-21 A & Science Ab Publ Diagnosis of candidiasis and candidemia or invasive candida infection
ES2359203B9 (en) * 2009-11-06 2013-02-19 Universidad Autonoma De Madrid (70%) MONCLONAL ANTIBODY THAT RECOGNIZES THE GAPDH PROTEIN OF FAMILY CANDIDA.
FR2993179B1 (en) * 2012-07-13 2016-01-08 Lesaffre & Cie YEAST SACCHAROMYCES CEREVISIAE FOR PREVENTING AND / OR TREATING VAGINAL MYCOSES
CN114933652B (en) * 2022-06-24 2023-03-28 丹娜(天津)生物科技股份有限公司 Anti-candida mannan monoclonal antibody and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023287A1 (en) * 1996-11-25 1998-06-04 The Research And Development Institute, Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023287A1 (en) * 1996-11-25 1998-06-04 The Research And Development Institute, Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
HAN Y ET AL: "A VACCINE AND MONOCLONAL ANTIBODIES THAT ENHANCE MOUSE RESISTANCE TO CANDIDA ALBICANS VAGINAL INFECTION", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 66, no. 12, 1998, pages 5771 - 5776, XP000907028, ISSN: 0019-9567 *
HAN YONGMOON ET AL: "Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody.", INFECTION AND IMMUNITY., vol. 68, no. 3, March 2000 (2000-03-01), pages 1649 - 1654, XP002196711, ISSN: 0019-9567 *
LI REN-KAI ET AL: "Chemical definition of an epitope-adhesin molecule on Candida albicans.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 24, 1993, pages 18293 - 18299, XP002196710, ISSN: 0021-9258 *
See also references of WO0052053A1 *
YONGMOON HAN ET AL: "BIOCHEMICAL CHARACTERIZATION OF CANDIDA ALBICANS EPITOPES THAT CAN ELICIT PROTECTIVE AND NONPROTECTIVE ANTIBODIES", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 65, no. 10, October 1997 (1997-10-01), pages 4100 - 4107, XP002929134, ISSN: 0019-9567 *
ZHANG M X ET AL: "MANNAN-SPECIFIC IMMUNOGLOBULIN G ANTIBODIES IN NORMAL HUMAN SERUM ACCELERATE BINDING OF C3 TO CANDIDA ALBICANS VIA THE ALTERNATIVE COMPLEMENT PATHWAY", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 66, no. 10, October 1998 (1998-10-01), pages 4845 - 4850, XP001058000, ISSN: 0019-9567 *

Also Published As

Publication number Publication date
EP1165614A1 (en) 2002-01-02
WO2000052053A1 (en) 2000-09-08
AU3861800A (en) 2000-09-21
JP2002541071A (en) 2002-12-03
CA2362840A1 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
IL145836A0 (en) Substituted azoles
AU6380200A (en) Protective body vest
EP1389923A4 (en) Protective collar
EP1278430A4 (en) Protective sleeve
AU2001283587A1 (en) Protective cover
GB2369864B (en) Protective covers
IL149775A0 (en) Protective material
EP1165614A4 (en) Antibodies against phosphomannan that are protective against candidiasis
GB0123935D0 (en) Dual function weather protection apparatus
IL146741A0 (en) Protective waistcoat
GB2347662B (en) Protective covering
GB0403888D0 (en) Protective packaging system
AU3372200A (en) Antibodies against hydrophobic proteins that are protective against candidiasis
GB0014920D0 (en) Protective device
GB9917698D0 (en) Ramguard protective cover
PL109683U1 (en) Protective dog-collar
GB9927886D0 (en) Protective covers
PL110984U1 (en) Protective cover
GB0021042D0 (en) Protective cover
AUPQ451199A0 (en) Protective cover
NZ513660A (en) Protective packaging system
GB0021783D0 (en) Protective system
PL109263U1 (en) Protective booth
PL109262U1 (en) Protective booth
PL109264U1 (en) Protective booth

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010925

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07K 16/00 A, 7A 61K 39/395 B, 7C 07K 16/14 B, 7G 01N 33/53 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020513

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030411

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030822